These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35691076)

  • 1. Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.
    Wu J; Yuan M; Shen J; Chen Y; Zhang R; Chen X; Wang H; Yin Z; Zhang X; Liu S; Sun Q
    Phytomedicine; 2022 Aug; 103():154229. PubMed ID: 35691076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophage-derived exosomal miR-513b-5p is a target of jianpi yangzheng decoction for inhibiting gastric cancer.
    Zhang R; Chen X; Miao C; Chen Y; Li Y; Shen J; Yuan M; Chen M; Cheng J; Liu S; Sun Q; Wu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117013. PubMed ID: 37572927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKM2 Is the Target of a Multi-Herb-Combined Decoction During the Inhibition of Gastric Cancer Progression.
    Sun Q; Yuan M; Wang H; Zhang X; Zhang R; Wang H; Chen X; Zhu M; Liu S; Wu J
    Front Oncol; 2021; 11():767116. PubMed ID: 34926270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Jian-pi-yang-zheng decoction inhibits gastric cancer progression via the macrophage immune checkpoint PI3Kγ.
    Yuan M; Zou X; Liu S; Xu X; Wang H; Zhu M; Xie X; Wang H; Wu J; Sun Q
    Biomed Pharmacother; 2020 Sep; 129():110440. PubMed ID: 32768942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Jianpi Yangzheng Xiaozheng Decoction and its components on gastric cancer.
    Wu J; Zhang XX; Zou X; Wang M; Wang HX; Wang YH; Li CY; Zhao LG; Chen M; Pei LX; Liu SL; Sun QM
    J Ethnopharmacol; 2019 May; 235():56-64. PubMed ID: 30731181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
    Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G
    Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
    Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells.
    Yang L; Zheng S; Liu Q; Liu T; Zhang Q; Han X; Tuerxun A; Lu X
    Oncol Rep; 2021 Oct; 46(4):. PubMed ID: 34396437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
    Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
    Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
    Zhao H; Jiang R; Feng Z; Wang X; Zhang C
    J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 Tumor-Associated Macrophages-Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression.
    Wang Y; Zhang J; Shi H; Wang M; Yu D; Fu M; Qian Y; Zhang X; Ji R; Wang S; Gu J; Zhang X
    Adv Sci (Weinh); 2024 Jun; 11(24):e2309298. PubMed ID: 38639382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic Tumor-Derived Exosomes Induce M2 Macrophage Polarization via PKM2/AMPK to Promote Lung Cancer Progression.
    Zhou S; Lan Y; Li Y; Li Z; Pu J; Wei L
    Cell Transplant; 2022; 31():9636897221106998. PubMed ID: 35818293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
    Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
    Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
    Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1.
    Chen Y; Liu J; Chen Y; Zhang R; Tao J; Chen X; Wang H; Sun Q; Wu J; Liu S
    Front Pharmacol; 2023; 14():1159829. PubMed ID: 37601051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
    Zhang C; Huang Z
    Mol Biotechnol; 2024 Jun; 66(6):1446-1457. PubMed ID: 37294531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
    Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
    Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
    Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
    Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.